Phase 3 clinical testing in the US of AstraZeneca COVID-19 vaccine candidate began
On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…
-
-
Vir Biotechnology and GSK started phase 2/3 study of COVID-19 antibody treatment
On Aug. 31, 2020, Vir Biotechnology and GlaxoSmithKline announced that the first patient was dosed in a phase…
-
Philips EV300 ventilator supply contract with US Department of Health and Human Services to end
On Aug. 31, 2020, Royal Philips announced that it had received notice from the U.S. Department of Health…
-
UConn launched funding program for COVID-19 research
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
-
T2 Biosystems received FDA Emergency Use Authorization for COVID-19 molecular diagnostic test
On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…
-
Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratory
On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
-
The US Dept of Veterans Affairs anounced new clinical trial for Veterans with COVID-19
On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…
-
Gileadﾒs investigational antiviral Vekluryﾮ (remdesivir) received FDA Emergency Use Authorization for treatment of patients with moderate COVID-19
On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…
-
iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
-
FDA expanded Emergency Use Authorization for Veklury (remdesivir) to include all hospitalized patients for treatment of COVID-19
On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
-
International research alliance launched to boost pandemic preparedness
On Aug. 27, 2020, scientists at Scripps Research announced they were partnering with peers in the U.S. and…
-
AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model
On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…
-
Todos Medical announced $4,500,000 contract for COVID-19 PCR testing equipment & supplies with New York-based laboratory
On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…
-
NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer research
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
-
BioNTech and Fosun Pharma to potentially supply 10 Million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV-2
On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…
-
National Science Foundation advanced artificial intelligence research with new nationwide institutes
On Aug. 26, 2020, the National Science Foundation (NSF) announced that it was establishing new artificial intelligence institutes…
-
Abbott’s fast, $5, 15-minute, easy-to-use COVID-19 antigen test for healthcare professionals received FDA Emergency Use Authorization
On Aug. 26, 2020, Abbott announced the FDA had issued Emergency Use Authorization (EUA) for its BinaxNOWﾙ COVID-19…
-
UConn received federal funding to develop self-administered microneedle COVID-19 vaccine technology
On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…
-
Altimmune and University of Alabama announced potent respiratory mucosal T cell responses in peclinical study of intranasal COVID-19 vaccine candidate
On Aug. 26, 2020, Altimmune announced additional positive results from the preclinical studies of its single-dose intranasal COVID-19…
-
Journal of American College of Cardiology published pioneering study using Stereotaxis robotic technology to treat pulmonary hypertension
On Aug. 26, 2020, Stereotaxis announced a pioneering publication in the prestigious Journal of the American College of…
-
Heat Biologics’ announced publication of preclinical COVID-19 vaccine results
On Aug. 26, 2020, Heat Biologics announced publication of positive preclinical COVID-19 results in bioRxiv. The company reported…
-
VBI Vaccines announced preclinical Coronavirus program data and selection of clinical candidates with potential one-dose vaccines
On Aug. 26, 2020, VBI Vaccines announced data from three preclinical mouse studies conducted to enable selection of…
-
Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
On Aug. 25, 2020, AstraZeneca announced that the first participants have been dosed in a Phase I trial…
-
Sinovac signed agreement with Bio Farma Indonesia for COVID-19 vaccine cooperation
On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio…
-
Intravacc and Therapyx jointly developed the world’s first prophylactic gonorrhea vaccine
On Aug. 25, 2020, Intravacc announced that it had partnered with American, Buffalo, NY, based Therapyx, to further…
-
Codex DNA building worldﾒs first vaccine printer and global vaccine network
On Aug. 25, 2020, Codex DNA announced critical advancements in its development of the Digital-to-Biological Converterﾙ (DBC) platform….
-
Trevena announced initiation of TRV027 study in COVID-19 patients in collaboration with Imperial College London
On Aug. 24, 2020,Trevena announced that Imperial College London (ICL) had initiated a proof-of-concept study for TRV027 in…
-
Man in Hong Kong was the first confirmed case of Coronavirus reinfection
On Aug. 24, 2020, Hong Kong University researchers reported that a 33-year-old man in Hong Kong had been…
-
NantKwest and ImmunityBio inked an agreement for joint development, manufacturing, marketing, and commercialization of COVID-19 vaccine
On Aug. 24 2020, NantKwest and ImmunityBio announced an agreement to jointly develop, manufacture, market, and commercialize therapeutics…
-
COVID-19 drug candidate Brilacidin achieved a selectivity index among the highest reported
On Aug. 24, 2020, Innovation Pharma reported receiving additional data from a U.S. Regional Biocontainment Laboratory (RBL) based…
